March 9, 2012 / 1:13 PM / in 6 years

Patheon posts loss as costs rise

(Reuters) - Contract drugmaker Patheon Inc PTI.TO reported its fourth consecutive quarterly loss hurt by higher costs.

First-quarter net loss was $19.4 million, or 15 cents per share, compared with a profit of $3.5 million, or 2.7 cents per share, a year ago.

Patheon said the consultation fees paid for the strategic review of its commercial business arm in the UK rose this quarter.

As a result selling, general and administrative expenses rose 24 percent to $34.5 million.

Revenue for Patheon, which provides contract development and manufacturing services to the pharmaceuticals industry, fell 12 percent to $153.9 million.

Shares of the company closed at C$1.85 on Thursday on the Toronto Stock Exchange.

(Reporting by Maneesha Tiwari in Bangalore; Editing by Gopakumar Warrier)

Corrects reporting currency to US dollars

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below